Previous close | 2.5000 |
Open | 2.5000 |
Bid | 0.0000 |
Ask | 4.6000 |
Strike | 600.00 |
Expiry date | 2024-10-18 |
Day's range | 2.5000 - 2.5000 |
Contract range | N/A |
Volume | |
Open interest | 6 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.